You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Claims for Patent: 10,266,597

✉ Email this page to a colleague

Summary for Patent: 10,266,597

Title:	Anti-CLL-1 antibodies and immunoconjugates
Abstract:	The invention provides anti-CLL-1 antibodies and immunoconjugates and methods of using the same.
Inventor(s):	Bing Zheng, Andrew Polson, Cecilia Chiu, Wei-Ching Liang, Yan Wu
Assignee:	Genentech Inc
Application Number:	US15/657,472

Details for Patent 10,266,597

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	September 25, 2009	⤷ Get Started Free	2037-07-24
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	December 30, 2009	⤷ Get Started Free	2037-07-24
Genentech, Inc.	ACTEMRA	tocilizumab	Injection	125276	January 08, 2010	⤷ Get Started Free	2037-07-24
Eli Lilly And Company	TALTZ	ixekizumab	Injection	125521	March 22, 2016	⤷ Get Started Free	2037-07-24
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,266,597

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016040868	⤷ Get Started Free
United States of America	9751946	⤷ Get Started Free
United States of America	2019248903	⤷ Get Started Free
United States of America	2018044421	⤷ Get Started Free
United States of America	2018044420	⤷ Get Started Free
United States of America	2018009894	⤷ Get Started Free
United States of America	2016075787	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.